Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert C.F. Leonard, MD, BS, MB
Charing Cross Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
66 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Basingstoke and North Hampshire Nhs Foundation Trust
Basingstoke, England, United Kingdom
- Royal United Hospital
Bath, England, United Kingdom
- Frenchay Hospital
Bristol, England, United Kingdom
- Addenbrooke'S Hospital
Cambridge, England, United Kingdom
- Halton Hospital
Cheshire, England, United Kingdom
- Essex County Hospital
Colchester, England, United Kingdom
- Dorset County Hospital
Dorchester, England, United Kingdom
- Russells Hall Hospital
Dudley, England, United Kingdom
- Queen Elizabeth Hospital
Gateshead, England, United Kingdom
- Diana Princess of Wales Hospital
Grimsby, England, United Kingdom
- Ucl Cancer Institute
Hampstead, London, England, United Kingdom
- Huddersfield Royal Infirmary
Huddersfield, West Yorks, England, United Kingdom
- King George Hospital
Ilford, Essex, England, United Kingdom
- Ipswich Hospital
Ipswich, England, United Kingdom
- Kidderminster Hospital
Kidderminster Worcestershire, England, United Kingdom
- Yorkshire Regional Clinical Trials & Research Unit
Leeds, England, United Kingdom
- Royal Liverpool University Hospital
Liverpool, England, United Kingdom
- Charing Cross Hospital
London, England, United Kingdom
- Guy'S Hospital
London, England, United Kingdom
- Helen Rollason Cancer Care Centre at North Middlesex Hospital
London, England, United Kingdom
- Homerton University Hospital
London, England, United Kingdom
- Newham University Hospital
London, England, United Kingdom
- Saint Bartholomew'S Hospital
London, England, United Kingdom
- St. George'S Hospital
London, England, United Kingdom
- Whipps Cross Hospital
London, England, United Kingdom
- Whittington Hospital
London, England, United Kingdom
- Luton and Dunstable Hospital
Luton-Bedfordshire, England, United Kingdom
- Maidstone Hospital
Maidstone, England, United Kingdom
- Christie Hospital
Manchester, England, United Kingdom
- North Manchester General Hospital - Penine Actute Hospitals Trust
Manchester, England, United Kingdom
- Clatterbridge Centre for Oncology
Merseyside, England, United Kingdom
- Mount Vernon Cancer Centre at Mount Vernon Hospital
Northwood, England, United Kingdom
- Norfolk and Norwich University Hospital
Norwich, England, United Kingdom
- Peterborough Hospitals Trust
Peterborough, England, United Kingdom
- Dorset Cancer Centre
Poole Dorset, England, United Kingdom
- Portsmouth Oncology Centre at Saint Mary'S Hospital
Portsmouth Hants, England, United Kingdom
- Oldchurch Hospital
Romford, England, United Kingdom
- Salisbury District Hospital
Salisbury, England, United Kingdom
- Scunthorpe General Hospital
Scunthorpe, England, United Kingdom
- Cancer Research Centre at Weston Park Hospital
Sheffield, England, United Kingdom
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2004
- Primary completion
- —
- Completion
- —
- Last update posted
- 7 Aug 2013
- Registered enrollment
- 400
- Registry id
- NCT00427245
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.